Loading clinical trials...
Loading clinical trials...
A Phase 2 Study Evaluating Safety and Efficacy of the Latanoprost Punctal Plug Delivery System (L PPDS)in Subjects With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG)
Conditions
Interventions
Latanoprost-PPDS
Locations
1
Canada
QLT Inc.
Vancouver, British Columbia, Canada
Start Date
October 1, 2010
Primary Completion Date
August 1, 2011
Completion Date
August 1, 2011
Last Updated
September 19, 2013
NCT07396441
NCT07390890
NCT05902871
NCT07218796
NCT07119580
NCT06865144
Lead Sponsor
Mati Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions